July 21, 2025 — NewsWall — Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) today announced a strategic restructuring that includes plans to sell its California operations.
The restructuring is part of the Company’s broader strategy to strengthen its balance sheet, increase cash flow, and prioritize markets with the highest margins and long-term growth potential. The Company is in active discussions with prospective buyers interested in acquiring its California assets, including cultivation, manufacturing, and select distribution operations.
Cresco Labs expects to finalize the transaction within the next several quarters, subject to customary closing conditions and regulatory approvals. Cresco Labs will retain full ownership of its premium FloraCal® brand and continue producing and marketing the brand across key U.S. markets.
Charlie Bachtell, CEO and Co-founder of Cresco Labs, said capital is increasingly precious, and their focus is on deploying it where it earns the strongest return. Bachtell added that while California is the largest cannabis market in the world, the structural challenges make it extremely difficult to generate sustainable profitability. He also noted that exiting California allows them to reallocate capital and resources to their core markets and build out new markets where they see clear pathways for growth and shareholder value.
Contact: Cresco Labs, Source: Cresco Labs
